1,178
Views
41
CrossRef citations to date
0
Altmetric
Review Article

Diagnosis of Ocular Tuberculosis

, FRCSEd, , MD, PhD, , MD, , MD, , MD, , MD, , MD & , FRCOphth, FRCS(G) show all
Pages 208-216 | Received 03 Dec 2015, Accepted 06 Apr 2016, Published online: 05 Jul 2016

REFERENCES

  • World Health Organization. Global Tuberculosis Report 2012. Geneva: WHO; 2012.
  • World Health Organization. Global tuberculosis control: key findings from the December 2009 WHO report. Wkly Epidemiol Rec. 2010;85:69–80.
  • Blumberg HM, Migliori GB, Ponomarenko O, et al. Tuberculosis on the move. Lancet. 2010;375:2127–2129.
  • Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–1843.
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis – an update. Surv Ophthalmol. 2007;52:561–587.
  • Garip A, Diedrichs-Mohring M, Thurau SR, et al. Uveitis in a patient treated with Bacille Calmette–Guerin: possible antigenic mimicry of mycobacterial and retinal antigens. Ophthalmology. 2009;116:2457–2462.
  • Spratt A, Key T, Vivian AJ. Chronic anterior uveitis following Bacille Calmette–Guerin vaccination: molecular mimicry in action? J Pediatr Ophthalmol Strabismus. 2008;45:252–253.
  • Abu El-Asrar AM, Abouammoh M, Al-Mezaine HS. Tuberculous uveitis. Int Ophthalmol Clin. 2010;50:19–39.
  • Ang M, Hedayatfar A, Zhang R, et al. Clinical signs of uveitis associated with latent tuberculosis. Clin Experiment Ophthalmol. 2012;40:689–696.
  • Ortega-Larrocea G, Bobadilla-del-Valle M, Ponce-de-Leon A, et al. Nested polymerase chain reaction for Mycobacterium tuberculosis DNA detection in aqueous and vitreous of patients with uveitis. Arch Med Res. 2003;34:116–119.
  • Sharma K, Gupta V, Bansal R, et al. Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthalmic Inflamm Infect. 2013;3:25.
  • Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology. 2002;109:851–857.
  • Ang M, Cheung G, Vania M, et al. Aqueous cytokine and chemokine analysis in uveitis associated with tuberculosis. Mol Vis. 2012;18:565–573.
  • Li J, Ang M, Cheung CM, et al. Aqueous cytokine changes associated with Posner-Schlossman syndrome with and without human cytomegalovirus. PLoS One. 2012;7:e44453.
  • Scheepers MA, Lecuona KA, Rogers G, et al. The value of routine polymerase chain reaction analysis of intraocular fluid specimens in the diagnosis of infectious posterior uveitis. ScientificWorld J. 2013;2013:545149.
  • Arora SK, Gupta V, Gupta A, et al. Diagnostic efficacy of polymerase chain reaction in granulomatous uveitis. Tuber Lung Dis. 1999;79:229–233.
  • Singh R, Toor P, Parchand S, et al. Quantitative polymerase chain reaction for Mycobacterium tuberculosis in so-called Eales’ disease. Ocul Immunol Inflamm. 2012;20:153–157.
  • Balne PK, Barik MR, Sharma S, et al. Development of a loop-mediated isothermal amplification assay targeting the mpb64 gene for diagnosis of intraocular tuberculosis. J Clin Microbiol. 2013;51:3839–3840.
  • World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy Update. Geneva: WHO; 2013.
  • Biswas J, Therese KL, Mahavan HN. Use of polymerase chain reaction in detection of Mycobacterium tuberculosis complex DNA from vitreous sample of Eales disease. Br J Ophthalmol. 1999;83:994.
  • Madhavan HN, Therese KL, Gunisha P, et al. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales’ disease. Invest Ophthalmol Vis Sci. 2000;41:822–825.
  • Sharma K, Bansal R, Sharma A, et al. Loop-mediated isothermal amplification for rapid diagnosis of tubercular uveitis. JAMA Ophthalmol. 2015;133:225–226.
  • Chauhan DS, Sharma VD, Parashar D, et al. Molecular typing of Mycobacterium tuberculosis isolates from different parts of India based on IS6110 element polymorphism using RFLP analysis. Indian J Med Res. 2007;125:577–581.
  • Balne PK, Modi RR, Choudhury N, et al. Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4:10.
  • Wroblewski KJ, Hidayat AA, Neafie RC, et al. Ocular tuberculosis: a clinicopathologic and molecular study. Ophthalmology. 2011;118:772–777.
  • Sharma K, Sharma A, Gupta A. Loop-mediated isothermal amplification for rapid diagnosis of tubercular uveitis – reply. JAMA Ophthalmol. 2015;133:226.
  • Sharma K, Bansal R, Sharma A, et al. Successful treatment of rifampicin-resistant intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23:93–96.
  • Abdelaal A, El-Ghaffar HA, Zaghloul MH, et al. Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial. Ann Clin Microbiol Antimicrob. 2009;8:4.
  • Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49:1–51.
  • Chee CB, Soh CH, Boudville IC, et al. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med. 2001;164:958–961.
  • Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis. 1993;17:968–975.
  • Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356:1099–1104.
  • Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull. 2010;93:69–84.
  • Lalvani A, Pareek M. Interferon gamma release assays: principles and practice. Enferm Infecc Microbiol Clin. 2010;28:245–252.
  • Tsiouri G, Gaitanis G, Kiorpelidou D, et al. Tuberculin skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis. Dermatology. 2009;219:119–125.
  • Harboe M, Oettinger T, Wiker HG, et al. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun. 1996;64:16–22.
  • Dillon DC, Alderson MR, Day CH, et al. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol. 2000;38:3285–3290.
  • Mahairas GG, Sabo PJ, Hickey MJ, et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol. 1996;178:1274–1282.
  • Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177–184.
  • Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340–354.
  • Ang M, Htoon HM, Chee SP. Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay. Ophthalmology. 2009;116:1391–1396.
  • Diel R, Goletti D, Ferrara G, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37:88–99.
  • Ang M, Wanling W, Chee SP. Clinical significance of an equivocal interferon gamma release assay result. Br J Ophthalmol. 2012;96:284–288.
  • Kleinert S, Kurzai O, Elias J, et al. Comparison of two interferon-gamma release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases. Ann Rheum Dis. 2010;69:782–784.
  • Williams KA, Esterman AJ, Bartlett C, et al. How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation. 2006;81:896–901.
  • Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:45–55.
  • Pareek M, Bond M, Shorey J, et al. Community-based evaluation of immigrant tuberculosis screening using interferon gamma release assays and tuberculin skin testing: observational study and economic analysis. Thorax. 2013;68:230–239.
  • Munoz L, Santin M. Interferon-gamma release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review. J Infect. 2013;66:381–387.
  • Ang M, Wong WL, Li X, et al. Interferon gamma release assay for the diagnosis of uveitis associated with tuberculosis: a Bayesian evaluation in the absence of a gold standard. Br J Ophthalmol. 2013;97:1062–1067.
  • Ang M, Wong W, Ngan CC, et al. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye (Lond). 2012;26:658–665.
  • Denkinger CM, Dheda K, Pai M. Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect. 2011;17:806–814.
  • Kardos M, Kimball AB. Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting. J Am Acad Dermatol. 2012;66:148–152.
  • Hardy AB, Varma R, Collyns T, et al. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Thorax. 2010;65:178–180.
  • Nienhaus A, Schablon A, Costa JT, et al. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res. 2011;11:247.
  • Ang M, Nguyen HV, Kiew SY, et al. Cost-effectiveness of alternative strategies for interferon-gamma release assays and tuberculin skin test in tuberculous uveitis. Br J Ophthalmol. 2015;99:984–989.
  • Agrawal R, Gonzalez-Lopez JJ, Nobre-Cardoso J, et al. Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence. Br J Ophthalmol 2016;100:348–355.
  • Sanghvi C, Bell C, Woodhead M, et al. Presumed tuberculous uveitis: diagnosis, management, and outcome. Eye (Lond). 2011;25:475–480.
  • Mancuso JD, Mazurek GH, Tribble D, et al. Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med. 2012;185:427–434.
  • La Distia Nora R, van Velthoven ME, Ten Dam-van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157:754–761.
  • Caspers L, Makhoul D, Ebraert H, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;158:646–647.
  • Gineys R, Bodaghi B, Carcelain G, et al. QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. Am J Ophthalmol. 2011;152:433–440.
  • Ang M, Hedayatfar A, Wong W, et al. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study. Br J Ophthalmol. 2012;96:332–336.
  • Fattorini L, Mustazzolu A, Piccaro G, et al. Drug-resistant tuberculosis among foreign-born persons in Italy. Eur Respir J. 2012;40:497–500.
  • Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010;149:562–570.
  • Varma D, Anand S, Reddy AR, et al. Tuberculosis: an under-diagnosed aetiological agent in uveitis with an effective treatment. Eye (Lond). 2006;20:1068–1073.
  • Tognon MS, Fiscon M, Mirabelli P, et al. Tuberculosis of the eye in Italy: a forgotten extrapulmonary localization. Infection. 2014;42:335–342.
  • Manousaridis K, Ong E, Stenton C, et al. Clinical presentation, treatment, and outcomes in presumed intraocular tuberculosis: experience from Newcastle upon Tyne, UK. Eye (Lond). 2013;27:480–486.
  • Eurosurveillance Editorial Team. ECDC and WHO/Europe joint report on tuberculosis surveillance and monitoring in Europe. Euro Surveill. 2014;19:20741.
  • Odone A, Ricco M, Morandi M, et al. Epidemiology of tuberculosis in a low-incidence Italian region with high immigration rates: differences between not Italy-born and Italy-born TB cases. BMC Public Health. 2011;11:376.
  • Guyton JS, Woods AC. Etiology of uveitis: a clinical study of 562 cases. Am J Ophthalmol. 1941;26:986–1018.
  • Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess. 2007;11:1–196.
  • Albini TA, Karakousis PC, Rao NA. Interferon-gamma release assays in the diagnosis of tuberculous uveitis. Am J Ophthalmol. 2008;146:486–488.
  • Ang M, Wong WL, Kiew SY, et al. Prospective head-to-head study comparing 2 commercial interferon gamma release assays for the diagnosis of tuberculous uveitis. Am J Ophthalmol. 2014;157:1306–1314.
  • Bansal R, Sharma K, Gupta A, et al. Detection of Mycobacterium tuberculosis genome in vitreous fluid of eyes with multifocal serpiginoid choroiditis. Ophthalmology. 2015;122:840–850.
  • Gupta V, Shoughy SS, Mahajan S, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm. 2015;23:14–24.
  • Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm. 2009;17:351–355.
  • Jeong YJ, Lee KS. Pulmonary tuberculosis: up-to-date imaging and management. AJR Am J Roentgenol. 2008;191:834–844.
  • Sarvananthan N, Wiselka M, Bibby K. Intraocular tuberculosis without detectable systemic infection. Arch Ophthalmol. 1998;116:1386–1388.
  • Joshi R, Patil S, Kalantri S, et al. Prevalence of abnormal radiological findings in health care workers with latent tuberculosis infection and correlations with T cell immune response. PLoS ONE. 2007;2:e805.
  • Ganesh SK, Roopleen, Biswas J, et al. Role of high-resolution computerized tomography (HRCT) of the chest in granulomatous uveitis: a tertiary uveitis clinic experience from India. Ocul Immunol Inflamm. 2011;19:51–57.
  • Mehta S. Patterns of systemic uptake of 18-FDG with positron emission tomography/computed tomography (PET/CT) studies in patients with presumed ocular tuberculosis. Ocul Immunol Inflamm. 2012;20:434–437.
  • Doycheva D, Deuter C, Hetzel J, et al. The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis. Br J Ophthalmol. 2011;95:1290–1294.
  • Mullerpattan JB, Udwadia ZF. Normal chest radiographs in sputum culture-positive pulmonary tuberculosis. Int J Tuberc Lung Dis. 2009;13:148–149.
  • Parashar D, Chauhan DS, Sharma VD, et al. Applications of real-time PCR technology to mycobacterial research. Indian J Med Res. 2006;124:385–398.
  • Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F, et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS ONE. 2006;1:e43.
  • Hernandez-Pando R, Jeyanathan M, Mengistu G, et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet. 2000;356:2133–2138.
  • Rao NA, Saraswathy S, Smith RE. Tuberculous uveitis: distribution of Mycobacterium tuberculosis in the retinal pigment epithelium. Arch Ophthalmol. 2006;124:1777–1779.
  • Biswas J, Madhavan HN, Gopal L, et al. Intraocular tuberculosis. Clinicopathologic study of five cases. Retina. 1995;15:461–468.
  • Park DY, Kim JY, Choi KU, et al. Comparison of polymerase chain reaction with histopathologic features for diagnosis of tuberculosis in formalin-fixed, paraffin-embedded histologic specimens. Arch Pathol Lab Med. 2003;127:326–330.
  • Forget EJ, Menzies D. Adverse reactions to first-line antituberculosis drugs. Expert Opin Drug Saf. 2006;5:231–249.
  • Lou SM, Montgomery PA, Larkin KL, et al. Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective. Ocul Immunol Inflamm. 2015;23:32–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.